Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy, 2nd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmacokinetics and Pharmacodynamics".
Deadline for manuscript submissions: 10 October 2024 | Viewed by 8595
Special Issue Editors
Interests: pediatrics; biostatistics; laboratory medicine; pharmacogenomics; renal elimination
Special Issues, Collections and Topics in MDPI journals
Interests: therapeutic drug monitoring; liquid chromatography-mass spectrometry; clinical pharmacokinetics; microsampling
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of therapeutic drug monitoring (TDM) is experiencing a revolution as it is becoming an important supporting tool for clinical decision making in various fields of pharmacotherapy. From the simplified evaluation of drug concentrations collected at the trough or, in certain cases, at other time points following drug administration, based on therapeutic ranges, this field has improved into one with a focus on providing in vivo pharmacokinetic information for the personalized modulation of drug regimens. The introduction of novel analytical and sampling technologies, as well as the availability of modern bioinformatic tools, including artificial intelligence and machine learning, have made important contributions to this rapid development.
This is the second volume of the Special Issue with the goal to mediate state-of-the-art scientific knowledge in the field of pharmacokinetics-based individualized drug therapy based on therapeutic drug monitoring. The aims have not changed: in this volume, contemporary, innovative research focusing on novel approaches to TDM and individualized drug regimens will be published with the perspective of improving patient care. The integration of clinical pharmacokinetic approaches with machine learning or artificial intelligence is of particular interest. Manuscripts enlightening the application of these tools to the assessment of patient adherence, countering adverse effects and events, establishing increased effectiveness and the safety of drug therapy, improving the cost-efficiency of treatments, or identifying patient sub-populations based on TDM, among others, will be considered for publication.
We express our appreciation to the authors of all submitted manuscripts for choosing this Special Issue to share their achievements. We are excited about Volume II, which is now open for the submission of high-quality manuscripts in the fields of therapeutic drug monitoring and pharmacokinetics-based individualized treatments.
Prof. Dr. Barna Vásárhelyi
Dr. Gellért Balázs Karvaly
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision pharmacotherapy
- population pharmacokinetic modeling probability of target attainment
- pharmacokinetic–pharmacodynamic index
- active metabolite
- adaptive control
- patient adherence
- chromatography
- mass spectrometry
- microsampling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.